TY  - CHAP
M1  - Book, Section
TI  - Future Challenges and Opportunities in Clinical Cancer Genomics
A1  - Glose, Kyle A.
A1  - Giovanni, Monica A.
A1  - Murray, Michael F.
A2  - Llor, Xavier
A2  - Hofstatter, Erin Wysong
Y1  - 2022
N1  - 
T2  - Cancer Genetics: A Clinical Approach
AB  - Cancer  is  the  second-leading  cause  of  death  in  the  United  States.1  We  can  imagine  a  future  where  both  germline  and  somatic  genomics  play  an  ever-increasing  role  in  decreasing  cancer  deaths  through  (1)  preemptive  identification  of  germline  cancer  risk,  (2)  early-stage  genomic  cancer  diagnoses,  and  (3)  genome-based  individually  tailored  therapeutics.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/18
UR  - hemonc.mhmedical.com/content.aspx?aid=1182367366
ER  -